Acutus Medical (AFIB)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	12.60 mm	12.60 mm	12.60 mm	12.60 mm	12.60 mm	12.60 mm
Cash burn (monthly)	244.00 k	1.54 mm	272.00 k	457.67 k	1.23 mm	3.80 mm
Cash used (since last report)	1.04 mm	6.57 mm	1.16 mm	1.95 mm	5.25 mm	16.18 mm
Cash remaining	11.56 mm	6.02 mm	11.44 mm	10.65 mm	7.35 mm	-3.59 mm
Runway (months of cash)	47.4	3.9	42.0	23.3	6.0	-0.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

AFIB institutional ownership history Ownership history

41.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	4	-25.0%
Opened positions	0	0
Closed positions	1	23	-95.7%
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	43.66 mm	43.89 mm	-0.5%
Total shares	12.46 mm	12.47 mm	-0.1%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Flynn James E	9.68 mm	$4.53 mm	0.0%
Advent Life Sciences	1.62 mm	$5.51 mm	0.0%
Fares Zahir	1.17 mm	$33.61 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
S.A. Mason	0.00	-6.40 k	EXIT
Flynn James E	9.68 mm	0.00	0.0%
Advent Life Sciences	1.62 mm	0.00	0.0%
Fares Zahir	1.17 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

AFIB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
27 Jan 25	Flynn James E	Warrant to Purchase Common Stock Class A Common Stock	Sale back to company	Dispose D	Yes	No	0.097	31,116	3.02 k	0
27 Jan 25	Flynn James E	Warrant to Purchase Common Stock Class A Common Stock	Sale back to company	Dispose D	Yes	No	0.097	193,002	18.72 k	0
27 Jan 25	Flynn James E	Warrant to Purchase Common Stock Class A Common Stock	Sale back to company	Dispose D	Yes	No	16.67	209,996	3.50 mm	0
27 Jan 25	Flynn James E	Warrant to Purchase Common Stock Class A Common Stock	Sale back to company	Dispose D	Yes	No	1.1114	1,889,509	2.10 mm	0
27 Jan 25	Flynn James E	Warrant to Purchase Common Stock Class A Common Stock	Sale back to company	Dispose D	Yes	No	1.1114	1,889,509	2.10 mm	0
1 Mar 24	Takeo Mukai	Form 4	Payment of exercise	Dispose F	No	No	0.21	8,475	1.78 k	72,874
6 Feb 24	Tom Sohn	Form 4	Payment of exercise	Dispose F	No	No	0.173	7,582	1.31 k	105,009
1 Feb 24	Takeo Mukai	Form 4	Payment of exercise	Dispose F	No	No	0.191	2,869	547.98	81,349
1 Feb 24	Tom Sohn	Form 4	Payment of exercise	Dispose F	No	No	0.191	5,709	1.09 k	112,591

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Acutus Medical Announces Operational Downsizing

4 Dec 24

CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk,

Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results

14 Nov 24

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (OTC:AFIB) today reported results for the third quarter and year-to-date of 2024. Recent Highlights: Third